A. Nogueira

Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis

C. E. Couri, A. Sposito, J. Barreto, 2021, Frontiers in Cardiovascular Medicine.

Increased particle size of triacylglycerol-enriched remnant lipoproteins, but not their plasma concentration or lipid content, augments risk prediction of incident type 2 diabetes

B. Duncan, I. Benseñor, P. Lotufo, 2020, Diabetologia.

Clinical and economic impact of coronary artery bypass graft and percutaneous coronary intervention in young individuals with acute coronary syndromes and multivessel disease: A real-world comparison in a middle-income country

A. Sposito, A. C. Nogueira, L. D. de Carvalho, 2022, Frontiers in Cardiovascular Medicine.

Aspirin in primary prevention and the risk of heart failure: a systematic review and meta‐analysis of controlled trials

C. Polanczyk, A. Sposito, J. Barreto, 2022, ESC heart failure.

The framing of time-dependent machine learning models improves risk estimation among young individuals with acute coronary syndromes

A. Sposito, A. C. Nogueira, M. D. Fernandez, 2023, Scientific Reports.

Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model

J. Gaziano, A. Sposito, L. F. Carvalho, 2023, Health Economics Review.